Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Dec;51(12):4329-35.
doi: 10.1128/AAC.00810-07. Epub 2007 Oct 15.

Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals

Affiliations

Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals

O Gutiérrez et al. Antimicrob Agents Chemother. 2007 Dec.

Abstract

All (236) Pseudomonas aeruginosa isolates resistant to imipenem and/or meropenem collected during a multicenter (127-hospital) study in Spain were analyzed. Carbapenem-resistant isolates were found to be more frequently resistant to all beta-lactams and non-beta-lactam antibiotics than carbapenem-susceptible isolates (P < 0.001), and up to 46% of the carbapenem-resistant isolates met the criteria used to define multidrug resistance (MDR). Pulsed-field gel electrophoresis revealed remarkable clonal diversity (165 different clones were identified), and with few exceptions, the levels of intra- and interhospital dissemination of clones were found to be low. Carbapenem resistance was driven mainly by the mutational inactivation of OprD, accompanied or not by the hyperexpression of AmpC or MexAB-OprM. Class B carbapenemases (metallo-beta-lactamases [MBLs]) were detected in a single isolate, although interestingly, this isolate belonged to one of the few epidemic clones documented. The MBL-encoding gene (bla(VIM-2)), along with the aminoglycoside resistance determinants, was transferred to strain PAO1 by electroporation, demonstrating its plasmid location. The class 1 integron harboring bla(VIM-2) was characterized as well, and two interesting features were revealed: intI1 was found to be disrupted by a 1.1-kb insertion sequence, and a previously undescribed aminoglycoside acetyltransferase-encoding gene [designated aac(6')-32] preceded bla(VIM-2). AAC(6')-32 showed 80% identity to AAC(6')-Ib' and the recently described AAC(6')-31, and when aac(6')-32 was cloned into Escherichia coli, it conferred resistance to tobramycin and reduced susceptibility to gentamicin and amikacin. Despite the currently low prevalence of epidemic clones with MDR, active surveillance is needed to detect and prevent the dissemination of these clones, particularly those producing integron- and plasmid-encoded MBLs, given their additional capacity for the intra- and interspecies spread of MDR.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Structure of the blaVIM-2 integron from plasmid pV2GY3 of P. aeruginosa strain GY3. The locations of the primers used for PCR amplification are also shown. IR, inverted repeat; approx., approximately.
FIG. 2.
FIG. 2.
Clustal W (version 1.83) multiple-sequence alignment of AAC(6′)-32, AAC(6′)-31 (26), and AAC(6′)-Ib′ (16). Dashes represent amino acid residues that are lacking in the indicated sequence relative to the sequence of AAC(6′)-32; asterisks indicate identical residues, colons indicate conserved substitutions, and dots indicate semiconserved substitutions.

Similar articles

Cited by

References

    1. Baquero, F. 2004. From pieces to patterns: evolutionary engineering in bacterial pathogens. Nat. Rev. Microbiol. 2:510-518. - PubMed
    1. Bouza, E., F. García-Garrote, E. Cercenado, M. Marin, and M. S. Diaz. 1999. Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. Antimicrob. Agents Chemother. 43:981-982. - PMC - PubMed
    1. Cavallo, J. D., R. Fabre, F. Leblanc, M. H. Nicolas-Chanoine, and A. Thabaut. 2000. Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a French multicentre study (1996). J. Antimicrob. Chemother. 46:133-136. - PubMed
    1. Cavallo, J. D., D. Hocquet, P. Plesiat, R. Fabre, and M. Roussel-Delvallez. 2007. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study. J. Antimicrob. Chemother. 59:1021-1024. - PubMed
    1. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing, vol. 26, no. 3, 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.

Publication types

MeSH terms

Associated data

LinkOut - more resources